From: CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity
FEV1
Gender
Age (years) (± SEM)
Severe
35.6 (3.13)
9 M / 6 F
24.7 (1.56)
Mild
77.4 (3.18)
9 M / 7 F
22.6 (1.37)